|
|
990 Washington Street, Suite 204 Dedham, MA 02026 USA phone:(617) 517-0095 fax:(617) 608-0232
|
|
| Symbol |
Private |
| Founded |
2004 |
| Employees |
|
|
|
| www.earlysense.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Automatic, Contact-Free Patient Monitoring System |
 |
| Management |
| Avner Halperin, Co-Founder and CEO; Danny Lange, Ph.D., Co-Founder and Chief Scientific Advisor; Amir Cohn, VP of Operations; Guy Meger, VP of R&D; Dalia Argaman, VP of Clinical and Regulatory Affairs; Yehuda Zicherman D.Sc., VP of Marketing; |
| |
|
|
| |
|
| Keywords |
| patient monitoring, PatientMonitoring, signal processing technology, vital signs |
|
|
|
| Description |
|
EarlySense is a medical device company developing and marketing wireless technology for the early detection of deteriorating health status. This can improve clinical outcomes while reducing dependence on patient compliance. |
 |
| Products / Services |
EverOn is a contact-free system that supervises the patient by continuously measuring heart and respiration rates as well as motion levels. The system alerts if there is a decline in the patient`s health status. It also detects bed entries and exits and patient turns. In addition, EverOn presents real time data and a continuous trend line.
|
 |
| Technology / Differentiation |
| The EverOn System allows for automatic, contact-less patient monitoring, which optimizes care without compromising lifestyle. |
 |
 |
| Status |
| The company's system received FDA and CE Mark approval in June 2009; it is currently undergoing pre-market testing in the U.S., Israel and Europe. |
 |
|
|
|
|
|
|